Krebs Biochemicals & Industries Limited
BSE: KREBSBIO.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Manish Kumar Jain
- Employees
- 191
- Headquarters
- Hyderabad, India
- IPO year
- 2004
- Market cap
- ₹1.3B
- Website
- https://krebsbiochem.com
Loading KREBSBIO…
Loading profile data…Frequently asked questions about KREBSBIO
What does Krebs Biochemicals & Industries Limited (KREBSBIO.BO) do?
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The...
Where does KREBSBIO.BO trade?
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) trades on the Bombay Stock Exchange.
What sector is KREBSBIO.BO in?
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Krebs Biochemicals & Industries Limited?
Manish Kumar Jain is the chief executive officer of Krebs Biochemicals & Industries Limited (KREBSBIO.BO).
Where is Krebs Biochemicals & Industries Limited headquartered?
Krebs Biochemicals & Industries Limited is headquartered in India.
Does KREBSBIO.BO pay a dividend?
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KREBSBIO.BO go public?
Krebs Biochemicals & Industries Limited (KREBSBIO.BO) completed its initial public offering in 2004.